Overview

The Efficacy of Bendamustine, Gemcytabine, Dexamethasone (BGD) Salvage Chemotherapy With Autologous Stem Cell Transplantation (ASCT) Consolidation in Advanced Classical Hodgkin Lymphoma Patients Not Responding to ABVD Therapy

Status:
Unknown status

Trial end date:
2021-05-06

Target enrollment:

Participant gender:

Summary

The objective of the study is evaluation of efficacy of Bendamustine, Gemcytabine, Dexamethasone (BGD) salvage therapy with autologus stem cell transplantation (ASCT) consolidation in advanced classical Hodgkin lymphoma patients not responding to ABVD therapy.

Phase:

Phase 2

Details

Lead Sponsor:

Polish Lymphoma Research Group

Treatments:

BB 1101
Bendamustine Hydrochloride
Dexamethasone
Dexamethasone acetate
Gemcitabine